- Previous Close
27,378.30 - Open
27,378.30 - Bid --
- Ask --
- Day's Range
27,378.30 - 27,926.30 - 52 Week Range
22,000.00 - 30,521.00 - Volume
11,597 - Avg. Volume
10,523 - Market Cap (intraday)
589.541B - Beta (5Y Monthly) 0.01
- PE Ratio (TTM)
45.87 - EPS (TTM)
604.37 - Earnings Date Jan 30, 2025 - Feb 3, 2025
- Forward Dividend & Yield 410.00 (1.48%)
- Ex-Dividend Date Jul 19, 2024
- 1y Target Est
28,117.14
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
www.abbott.co.in3,814
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ABBOTINDIA.NS
View MorePerformance Overview: ABBOTINDIA.NS
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABBOTINDIA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABBOTINDIA.NS
View MoreValuation Measures
Market Cap
589.54B
Enterprise Value
571.29B
Trailing P/E
45.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.71
Price/Book (mrq)
16.73
Enterprise Value/Revenue
9.42
Enterprise Value/EBITDA
31.53
Financial Highlights
Profitability and Income Statement
Profit Margin
21.18%
Return on Assets (ttm)
19.22%
Return on Equity (ttm)
38.75%
Revenue (ttm)
60.66B
Net Income Avi to Common (ttm)
12.85B
Diluted EPS (ttm)
604.37
Balance Sheet and Cash Flow
Total Cash (mrq)
11.06B
Total Debt/Equity (mrq)
1.72%
Levered Free Cash Flow (ttm)
1.11B